BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18472076)

  • 1. [Management of testicular seminoma with elevation of alpha fetoprotein. A case report].
    Durand X; Vedrine L; Deligne E; Desfemmes FR; Ceccaldi B; Houlgatte A
    Prog Urol; 2008 Mar; 18(3):190-2. PubMed ID: 18472076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical parameters that predict histology of postchemotherapy retroperitoneal lymph node mass in testicular cancer.
    Onozawa M; Kawai K; Yamamoto T; Hinotsu S; Tsukamoto S; Hattori K; Miyanaga N; Shimazui T; Akaza H
    Int J Urol; 2004 Jul; 11(7):535-41. PubMed ID: 15242364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of retroperitoneal lymph node dissection after chemotherapy in patients with pure seminoma in the orchidectomy specimen but elevated serum alpha-fetoprotein.
    Peterson M; Beck S; Bihrle R; Einhorn L; Foster R
    BJU Int; 2009 Jul; 104(2):176-8. PubMed ID: 19493258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of advanced seminoma: retrospective study of 96 patients].
    Bompas E; Fléchon A; Biron P; Droz JP
    Bull Cancer; 2002 Oct; 89(10):877-85. PubMed ID: 12441279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Two cases of testicular tumors with high alpha-fetoprotein levels: a case report].
    Funahashi M; Tuchiya F; Makiyama K; Sugiura S; Miyoshi Y; Kishida T; Ogawa T; Uemura H; Yao M; Kubota Y
    Hinyokika Kiyo; 2005 Feb; 51(2):133-7. PubMed ID: 15773370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
    Nolan L; Wheater M; Kirby J; Simmonds P; Mead G
    BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
    Beck SD; Patel MI; Sheinfeld J
    J Urol; 2004 Jan; 171(1):168-71. PubMed ID: 14665869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
    Beck SD; Foster RS; Bihrle R; Donohue JP
    Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis.
    Heidenreich A; Thüer D; Polyakov S
    Eur Urol; 2008 Feb; 53(2):260-72. PubMed ID: 18045770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When is a Seminoma not a Seminoma? The Incidence, Risk Factors and Management of Patients With Testicular Seminoma With Discordant Elevated Serum Alpha-fetoprotein.
    Fero KE; Lec PM; Sharma V; Lenis AT; Low J; Litwin MS; Leapman MS; Chamie K
    Urology; 2021 Nov; 157():188-196. PubMed ID: 34389428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?
    Mosharafa AA; Foster RS; Leibovich BC; Bihrle R; Johnson C; Donohue JP
    J Urol; 2003 Jun; 169(6):2126-8. PubMed ID: 12771733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lectin-reactive alpha-fetoprotein as a marker for testicular tumor activity.
    Kawai K; Kojima T; Miyanaga N; Hattori K; Hinotsu S; Shimazui T; Akaza H
    Int J Urol; 2005 Mar; 12(3):284-9. PubMed ID: 15828957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroperitoneal lymph node dissection after chemotherapy in patients with elevated tumour markers: indications, histopathology and outcome.
    Ong TA; Winkler MH; Savage PM; Seckl MJ; Christmas TJ
    BJU Int; 2008 Jul; 102(2):198-202. PubMed ID: 18294302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?
    Spiess PE; Brown GA; Pisters LL; Liu P; Tu SM; Evans JG; Kamat AM; Black P; Tannir NM
    Cancer; 2006 Oct; 107(7):1503-10. PubMed ID: 16944534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of primary testicular seminoma: a report on 57 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    Cancer Res; 2000 Apr; 60(8):2152-4. PubMed ID: 10786678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giant testicular seminoma.
    Ellimoottil C; Quek ML
    Urology; 2012 Oct; 80(4):e35-6. PubMed ID: 22901819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of localized germ-cell tumours of the testis].
    Loriot Y; Fizazi K
    Rev Prat; 2007 Feb; 57(4):379-84. PubMed ID: 17455739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy for metastatic germ cell tumours of the testis].
    Culine S
    Rev Prat; 2007 Feb; 57(4):385-8. PubMed ID: 17455740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The place of surgery in the treatment of seminomatous testicular tumors.
    Smith RB
    Prog Clin Biol Res; 1984; 153():111-9. PubMed ID: 6206504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonpalpable testicular pure seminoma with elevated serum alpha-fetoprotein presenting with retroperitoneal metastasis: a case report.
    Iwatsuki S; Naiki T; Kawai N; Etani T; Iida K; Ando R; Nagai T; Okada A; Tozawa K; Sugiyama Y; Yasui T
    J Med Case Rep; 2016 May; 10(1):114. PubMed ID: 27150447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.